These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 16983269)

  • 1. Soluble CD163: An age-dependent, anti-inflammatory biomarker predicting outcome in sepsis.
    Weiss M; Schneider EM
    Crit Care Med; 2006 Oct; 34(10):2682-3. PubMed ID: 16983269
    [No Abstract]   [Full Text] [Related]  

  • 2. Macrophage serum markers in pneumococcal bacteremia: Prediction of survival by soluble CD163.
    Møller HJ; Moestrup SK; Weis N; Wejse C; Nielsen H; Pedersen SS; Attermann J; Nexø E; Kronborg G
    Crit Care Med; 2006 Oct; 34(10):2561-6. PubMed ID: 16915112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New immunological serum markers in bacteraemia: anti-inflammatory soluble CD163, but not proinflammatory high mobility group-box 1 protein, is related to prognosis.
    Gaïni S; Pedersen SS; Koldkaer OG; Pedersen C; Moestrup SK; Møller HJ
    Clin Exp Immunol; 2008 Mar; 151(3):423-31. PubMed ID: 18190604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble CD163.
    Møller HJ
    Scand J Clin Lab Invest; 2012 Feb; 72(1):1-13. PubMed ID: 22060747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble hemoglobin-haptoglobin scavenger receptor CD163 as a lineage-specific marker in the reactive hemophagocytic syndrome.
    Schaer DJ; Schleiffenbaum B; Kurrer M; Imhof A; Bächli E; Fehr J; Moller HJ; Moestrup SK; Schaffner A
    Eur J Haematol; 2005 Jan; 74(1):6-10. PubMed ID: 15613100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum markers of macrophage activation in pre-eclampsia: no predictive value of soluble CD163 and neopterin.
    Kronborg CS; Knudsen UB; Moestrup SK; Allen J; Vittinghus E; Møller HJ
    Acta Obstet Gynecol Scand; 2007; 86(9):1041-6. PubMed ID: 17712642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis.
    Bleesing J; Prada A; Siegel DM; Villanueva J; Olson J; Ilowite NT; Brunner HI; Griffin T; Graham TB; Sherry DD; Passo MH; Ramanan AV; Filipovich A; Grom AA
    Arthritis Rheum; 2007 Mar; 56(3):965-71. PubMed ID: 17328073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD163 as a valuable diagnostic and prognostic biomarker of sepsis-associated hemophagocytic lymphohistiocytosis in critically ill children.
    Cui Y; Xiong X; Ren Y; Wang F; Wang C; Zhang Y
    Pediatr Blood Cancer; 2019 Oct; 66(10):e27909. PubMed ID: 31298489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of soluble CD163 as a marker of inflammation in psoriasis.
    Feighery C; Dunne J; Bingham EA; Feighery CF
    Clin Exp Dermatol; 2011 Mar; 36(2):201-3. PubMed ID: 21323937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma level of the macrophage-derived soluble CD163 is increased and positively correlates with severity in Gaucher's disease.
    Møller HJ; de Fost M; Aerts H; Hollak C; Moestrup SK
    Eur J Haematol; 2004 Feb; 72(2):135-9. PubMed ID: 14962251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The macrophage activation marker sMR as a diagnostic and prognostic marker in patients with acute infectious disease with or without sepsis.
    Marie Relster M; Gaini S; Møller HJ; Johansen IS; Pedersen C
    Scand J Clin Lab Invest; 2018 May; 78(3):180-186. PubMed ID: 29383956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human monocyte CD163 expression inversely correlates with soluble CD163 plasma levels.
    Davis BH; Zarev PV
    Cytometry B Clin Cytom; 2005 Jan; 63(1):16-22. PubMed ID: 15624200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble CD163, a unique biomarker to evaluate the disease activity, exhibits macrophage activation in systemic juvenile idiopathic arthritis.
    Sakumura N; Shimizu M; Mizuta M; Inoue N; Nakagishi Y; Yachie A
    Cytokine; 2018 Oct; 110():459-465. PubMed ID: 29801971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in fat mass correlate with changes in soluble sCD163, a marker of mature macrophages, in patients with CKD.
    Axelsson J; Møller HJ; Witasp A; Qureshi AR; Carrero JJ; Heimbürger O; Bárány P; Alvestrand A; Lindholm B; Moestrup SK; Stenvinkel P
    Am J Kidney Dis; 2006 Dec; 48(6):916-25. PubMed ID: 17162146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophil and monocyte activation markers have prognostic impact in disseminated intravascular coagulation: in vitro effect of thrombin on monocyte CD163 shedding.
    Chung S; Kim JE; Park S; Han KS; Kim HK
    Thromb Res; 2011 May; 127(5):450-6. PubMed ID: 21255822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage activation syndrome: serological markers and treatment with anti-thymocyte globulin.
    Coca A; Bundy KW; Marston B; Huggins J; Looney RJ
    Clin Immunol; 2009 Jul; 132(1):10-8. PubMed ID: 19297252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of monocyte CD163 in single- and dual-asthmatic responders during allergen-induced bronchoconstriction.
    Kowal K; Møller HJ; Dubuske LM; Moestrup SK; Bodzenta-Lukaszyk A
    Clin Exp Allergy; 2006 Dec; 36(12):1584-91. PubMed ID: 17177682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble haemoglobin scavenger receptor (sCD163) in patients with suspected community-acquired infections.
    Gaïni S; Koldkjaer OG; Pedersen SS; Pedersen C; Moestrup SK; Møller HJ
    APMIS; 2006 Feb; 114(2):103-11. PubMed ID: 16519746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteolytic shedding of the macrophage scavenger receptor CD163 in multiple sclerosis.
    Fabriek BO; Møller HJ; Vloet RP; van Winsen LM; Hanemaaijer R; Teunissen CE; Uitdehaag BM; van den Berg TK; Dijkstra CD
    J Neuroimmunol; 2007 Jul; 187(1-2):179-86. PubMed ID: 17537523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic macrophage activation predicts clinical decompensation in chronic liver disease.
    Rode A; Nicoll A; Møller HJ; Lim L; Angus PW; Kronborg I; Arachchi N; Gorelik A; Liew D; Kazankov K; Vilstrup H; Grønbæk H
    Gut; 2013 Aug; 62(8):1231-2. PubMed ID: 23442440
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.